Introgen Therapeutics, Inc. (INGN)
$0.01
0.00 (0%)
| CAPS Rating |
|
|---|---|
| Open | $0.00 |
| Previous Close | $0.01 |
| Daily Range | $0.01 - $0.02 |
| 52-Week Range | $0.01 - $0.60 |
| Market Cap | $0.57M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 0 |
| Average Daily Volume | 50,000 |
INGN
VS S&P 500 (SPY)
This ticker is not currently Ratable.
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
INGN Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
INGN News and Commentary
- Illuminating Illumina – The Motley Fool
- Wednesday's Biggest Stock Stars – The Motley Fool
- Making Cents in Penny Stocks – The Motley Fool
- 7 Surprising 1-Star Stocks – The Motley Fool
- Another Blow to Gene Therapy – The Motley Fool
- Here Come the Dendreon Lawsuits – The Motley Fool
- Is Introgen Stringing Investors Along? – The Motley Fool
- Learn From Northfield's Bloody Results – The Motley Fool
- Patents Shine, but Don't Be Blinded by Them – The Motley Fool
- Introgen's Still Standing -- for Now – The Motley Fool
- 7 Surprising 1-Star Stocks – The Motley Fool
Related News and Articles
- This Big Winner Has Hit Its Prime – The Motley Fool
- Dream Stocks for Biotech Investors – The Motley Fool
- Still Enjoying Those Acquisitions, Pfizer? – The Motley Fool
- Novartis Didn't Know JAK, Until Now – The Motley Fool
- 4 Platform Drugmakers to Invest In – The Motley Fool
- 10 Stocks Shaking the Market – The Motley Fool
- A Big Upgrade for Allos Therapeutics – The Motley Fool
RSS Headlines
Fool UK
